Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
9.93
-0.04 (-0.45%)
Oct 13, 2025, 11:46 AM EDT - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
Affordable Medicines
1.69B
Log In
Log In
Log In
Log In
Upgrade
Affordable Medicines Growth
14.53%
Log In
Log In
Log In
Log In
Upgrade
AvKARE
662.95M
Log In
Log In
Log In
Log In
Upgrade
AvKARE Growth
24.67%
Log In
Log In
Log In
Log In
Upgrade
Specialty
445.75M
Log In
Log In
Log In
Log In
Upgrade
Specialty Growth
14.16%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202003 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2003 - 2019
United States, India and Ireland
2.79B
Log In
Log In
Log In
Log In
Upgrade
United States, India and Ireland Growth
16.73%
Log In
Log In
Log In
Log In
Upgrade